Details
| Stereochemistry | RACEMIC |
| Molecular Formula | 2C16H20N2O2.C6H8O7 |
| Molecular Weight | 736.8079 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)CC(O)(CC(O)=O)C(O)=O.OC(CN1CCCCC1)C2=NOC(=C2)C3=CC=CC=C3.OC(CN4CCCCC4)C5=NOC(=C5)C6=CC=CC=C6
InChI
InChIKey=OOSOWXQJLLTIAF-UHFFFAOYSA-N
InChI=1S/2C16H20N2O2.C6H8O7/c2*19-15(12-18-9-5-2-6-10-18)14-11-16(20-17-14)13-7-3-1-4-8-13;7-3(8)1-6(13,5(11)12)2-4(9)10/h2*1,3-4,7-8,11,15,19H,2,5-6,9-10,12H2;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)
| Molecular Formula | C16H20N2O2 |
| Molecular Weight | 272.3422 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
| Molecular Formula | C6H8O7 |
| Molecular Weight | 192.1235 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: http://www.ncbi.nlm.nih.gov/pubmed/6489869Curator's Comment: Description was created based on several sources, including http://www.drugfuture.com/chemdata/perisoxal.html
Sources: http://www.ncbi.nlm.nih.gov/pubmed/6489869
Curator's Comment: Description was created based on several sources, including http://www.drugfuture.com/chemdata/perisoxal.html
Perisoxal citrate is a basic nonsteroidal anti-inflammatory and analgesic drug.
Approval Year
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
Sources: http://www.ncbi.nlm.nih.gov/pubmed/397126 |
Palliative | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Determination of perisoxal and its phenolic metabolites in rat, rabbit and human urine. | 1980-07 |
|
| Absorption, excretion, distribution and metabolism of perisoxal in rats. | 1979-05 |
|
| [Clinical trial of a new non-steroidal anti-inflammatory analgesic, 31252-S, for postoperative pain following tooth extraction and minor ambulatory surgery]. | 1979 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/7448957
200 mg/man, p. o
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 21:24:48 GMT 2025
by
admin
on
Mon Mar 31 21:24:48 GMT 2025
|
| Record UNII |
THV8Y61BB4
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
CHEMBL2105453
Created by
admin on Mon Mar 31 21:24:48 GMT 2025 , Edited by admin on Mon Mar 31 21:24:48 GMT 2025
|
PRIMARY | |||
|
SUB03712MIG
Created by
admin on Mon Mar 31 21:24:48 GMT 2025 , Edited by admin on Mon Mar 31 21:24:48 GMT 2025
|
PRIMARY | |||
|
218465
Created by
admin on Mon Mar 31 21:24:48 GMT 2025 , Edited by admin on Mon Mar 31 21:24:48 GMT 2025
|
PRIMARY | |||
|
m1221
Created by
admin on Mon Mar 31 21:24:48 GMT 2025 , Edited by admin on Mon Mar 31 21:24:48 GMT 2025
|
PRIMARY | Merck Index | ||
|
THV8Y61BB4
Created by
admin on Mon Mar 31 21:24:48 GMT 2025 , Edited by admin on Mon Mar 31 21:24:48 GMT 2025
|
PRIMARY | |||
|
100000085697
Created by
admin on Mon Mar 31 21:24:48 GMT 2025 , Edited by admin on Mon Mar 31 21:24:48 GMT 2025
|
PRIMARY | |||
|
2139-25-5
Created by
admin on Mon Mar 31 21:24:48 GMT 2025 , Edited by admin on Mon Mar 31 21:24:48 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |